The use of herbal medicines by people with cancer: a cross-sectional survey

被引：71
作者：
Damery, S. [1 ]
Gratus, C. [1 ]
Grieve, R. [2 ]
Warmington, S. [1 ]
Jones, J. [1 ]
Routledge, P. [3 ]
Greenfield, S. [1 ]
Dowswell, G. [1 ]
Sherriff, J. [2 ]
Wilson, S. [1 ]
机构：
[1] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Hosp Coventry & Warwickshire NHS Trust, Arden Canc Res Ctr, Coventry CV2 2DX, W Midlands, England
[3] Cardiff Univ, Sect Pharmacol Therapeut & Toxicol, Cardiff CF14 4XN, S Glam, Wales
来源：
BRITISH JOURNAL OF CANCER | 2011年 / 104卷 / 06期
关键词：
herbal medicines; survivorship; prevalence; COMPLEMENTARY THERAPY USE; BREAST-CANCER; PREVALENCE; WOMEN; UK;
D O I：
10.1038/bjc.2011.47
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
BACKGROUND: A large proportion of cancer patients are estimated to use herbal medicines, but data to substantiate this are lacking. This study aimed to investigate the prevalence of herbal medicine use among cancer patients in the West Midlands, and determine the characteristics predicting herbal medicine use. METHODS: A cross-sectional survey of oncology patients (n = 1498) being followed up at a hospital in Coventry was undertaken. Recipients were asked about herbal medicine use since their cancer diagnosis, and the association between sociodemographic and cancer-related characteristics and herbal medicine use was evaluated. RESULTS: A total of 1134 responses were received (75.7%). The prevalence of herbal medicine use was 19.7% (95% CI: 17.4-22.1; n = 223). Users were more likely to be affluent, female, and aged under 50 years. Usage increased with time since cancer diagnosis (X-2 for trend 4.63; P = 0.031). A validation data set, derived from a survey of oncology patients in Birmingham ( n 541) with differing socioeconomic characteristics showed no significant difference in estimated prevalence (16.6%; 95% CI: 11.9-22.2). CONCLUSION: A substantial number of people with cancer are likely to be taking herbal medicines. Understanding the self-medication behaviours of these individuals is essential if health-care professionals are to support treatment adherence and avoid unwanted pharmacological interactions. British Journal of Cancer (2011) 104, 927-933. doi: 10.1038/bjc.2011.47 www.bjcancer.com
引用
收藏
页码：927 / 933
页数：7
相关论文
共 32 条
  • [1] ALI N, 2005, DIVERSITY HLTH SOCIA, V2, P41
  • [2] [Anonymous], 1994, INT STAT CLASS DIS R
  • [3] [Anonymous], 2009, Cancer incidence and survival by major ethnic group, England, 2002 - 2006
  • [4] Astin John A, 2006, J Soc Integr Oncol, V4, P157, DOI 10.2310/7200.2006.019
  • [5] Beyond convention: describing complementary therapy use by women living with breast cancer
    Balneaves, LG
    Kristjanson, LJ
    Tataryn, D
    [J]. PATIENT EDUCATION AND COUNSELING, 1999, 38 (02) : 143 - 153
  • [6] What non-prescription treatments do UK women with breast cancer use?
    Catt, S.
    Fallowfield, L.
    Langridge, C.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2006, 15 (03) : 279 - 285
  • [7] Corner J, 2006, STUDY USE COMPLEMENT
  • [8] The use of complementary therapies by breast cancer patients attending conventional treatment
    Crocetti, E
    Crotti, N
    Feltrin, A
    Ponton, P
    Geddes, M
    Buiatti, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 (03) : 324 - 328
  • [9] Department for Communities and Local Government, 2007, IND MULT DEPR
  • [10] PURSUIT AND PRACTICE OF COMPLEMENTARY THERAPIES BY CANCER-PATIENTS RECEIVING CONVENTIONAL TREATMENT
    DOWNER, SM
    CODY, MM
    MCCLUSKEY, P
    WILSON, PD
    ARNOTT, SJ
    LISTER, TA
    SLEVIN, ML
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6947) : 86 - 89
1234